Having trouble viewing this email? View in your browser.
ESCMID Logo

27 December 2016
WEEKLY NEWS

Dear colleagues,

Nominations for the TAE Awards for Training Achievements 2017 will be accepted until 5 January 2017, 12.00 noon CET.

Season's greetings, your ESCMID communications editors

 

Course on (re-)emerging arbovirus infections, 29 – 31 March in Zagreb

The aim of the course is to improve participants’ knowledge of identification and management of arbovirus infections and outbreaks at a local and European level. The course is part of PREPARE, an EU-funded partnership aimed at strengthening European preparedness for (re-) emerging infectious disease outbreaks. Course topics will include a review of arboviruses of clinical importance to Europe, including endemic and travel imported viruses. This will include an overview of symptomatology, diagnostics and interpretation of laboratory results and an update on prevention, vaccine and treatments. The course will also include an overview of surveillance systems, European organizations, laboratories and clinical networks involved in surveillance, control and outbreak response and interactive sessions covering serology interpretation, case scenarios and outbreak response exercises. The course will be delivered by a range of European experts on arboviruses, through a dynamic mix of presentations, case scenarios and outbreak exercises.

› Read more
 

CMI highlight: microbiome assessment of medical marijuana

Immunocompromised patients in some countries are prescribed marijuana to control nausea or pain. But there is little data available on the infectious risks of medical marijuana. Researchers in the U.S. assessed the microbiome of twenty cannabis samples from different dispensaries in northern California. They found evidence for the presence of numerous Gram-negative bacilli and fungal pathogens. The authors conclude that it would be prudent to advise immunocompromised patients against the use of vaporized or inhaled marijuana because it places them at an increased risk for acquisition of severe infections.

› Read more
 

Workshop on HAIs, 24 – 25 March in Muscat, Oman

The course on hospital-acquired infections (HAIs) takes place from 24 – 25 March 2017 in Muscat, Oman. The workshop aims at reviewing existing knowledge, ongoing studies, identifying gaps and priorities for prevention and control of multidrug-resistant HAI in LMIC with particular focus on Gram-negative bacteria, respiratory and bloodstream infections. After discussing the design of high-quality studies (including randomized controlled trials) to test agreed interventions, participants will continue discussions in their home institutions and become involved in developing further studies to advance knowledge and introduce interventions to reduce the burden of HAIs.

› Read more
ESCMID Executive Office
P.O. Box 214
4010 Basel
Switzerland
Phone +41 61 5080 173
info@escmid.org
www.escmid.org
Follow ESCMID
Visit us on LinkedIn Visit us on YouTube
 
The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.

Tip: To ensure that you receive the ESCMID newsletter in your inbox, add newsletter@escmid.org to your email program’s address book.

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.